Navigation Links
Do Statins Lower Male Sex Drive?
Date:4/15/2010

Italian study says yes, but earlier U.S. study had different conclusion

THURSDAY, April 15 (HealthDay News) -- An Italian study of men being treated for erectile dysfunction finds an association between the use of cholesterol-lowering statins and abnormally low levels of the male hormone testosterone.

The study "sends a signal worthy of observation," said Dr. Irwin Goldstein, director of sexual medicine at Alvarado Hospital in San Diego and editor of the Journal of Sexual Medicine. The report is published in the April issue of the journal.

Goldstein noted that, in his practice, he sees patients "several times a week" who say that their sexual performance declined after they started taking a statin.

But an American epidemiologist who did a similar study said the Italian results could be interpreted as saying that statin use reduces the incidence of erectile dysfunction.

That study, of men in Olmsted County, Minn., found a low incidence of impotence in men taking the drugs, with longer use associated with lower incidence. Men who took statins for nine years were 64 percent less likely to develop erectile dysfunction in that study than those who didn't, said study co-author Jennifer St. Sauver, an epidemiologist at the Mayo Clinic.

The apparently contradictory results could be explained by the different populations in the two studies, St. Sauver said. The Minnesota study included men in the general population, while the Italian study looked only at men being treated for erectile dysfunction.

Thirty percent of the Minnesota men were taking statins. Only 7 percent of the 3,484 men in the Italian study were taking the drugs. The U.S. Centers for Disease Control and Prevention has reported that about 16 percent of U.S. adults use statins. The lower percentage in the Italian study could indicate that statins reduce the need to seek treatment for erectile dysfunction, St. Sauver said.

The Italian study also didn't have a control group of men without sexual problems, she said, so to establish any cause-effect relationship "you would have to take a group of men without erectile dysfunction and see how many are taking statins," St. Sauver said.

Men who take statins and have sexual problems shouldn't stop taking the drug, Goldstein said. "They should see a doctor for a blood test," he said. "If testosterone is low, they should not stop taking statins but should start testosterone treatment."

The Italian study is important because "it is the first to bring up this message in a large number of men," Goldstein added.

One U.S. study, reported in 2007 by the New England Research Institutes, did find lower levels of testosterone in a general population of men taking statins. But detailed analysis of the data found that the reduced levels could be explained by other factors, such as obesity and diabetes, rather than statin use.

That study was done because of reports that statins might lower the risk of prostate cancer by reducing testosterone levels. No such protective effect was found.

Several scattered studies have found a relationship between statin use and lower levels of male hormones. But definitive evidence about such a relationship would require a carefully controlled study, Goldstein said.

More information

Detailed information on statins is given by the U.S. National Library of Medicine.



SOURCES: Irwin Goldstein, M.D., director, sexual medicine, Alvarado Hospital, San Diego; Jennifer St. Sauver, Ph.D., Mayo Clinic, Rochester, Minn.; April 2010, Journal of Sexual Medicine


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Statins May Slow Progression of Multiple Sclerosis, New Study Finds
2. Statins may slow progression of multiple sclerosis, new study finds
3. Alternative to Statins Shows Promise
4. Statins May Benefit Prostate Cancer Patients
5. Statins Show Promise Against Sickle Cell
6. More Evidence That Statins Cut Stroke Risk
7. HD Telepresence Gets More Affordable for SMBs: XVD Espresso HD Delivers Higher Performance at Lower Costs than Traditional Solutions
8. Exposure to nitrogen dioxide lowers in vitro fertilization success
9. Seeing Letter F May Lower Test Scores
10. Preventive Mastectomy May Not Lower Risks
11. IRS Whistleblower Office Makes Good Again: Kenney & McCafferty Whistleblowers Receive Full Reward
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... ... 06, 2016 , ... Norwood Insurance Group, serving families of ... their ongoing community enrichment program. The current campaign is being extended to continue ... more months of treatments, leaving his family in great need of financial assistance. ...
(Date:5/6/2016)... ... May 06, 2016 , ... ... charity program created to support and assist the people of their local community. ... with nonprofit organizations and community leaders. Their desire is to bring awareness to ...
(Date:5/6/2016)... ... May 06, 2016 , ... DrugDev President ... the way the pharmaceutical industry conducts clinical trials. This month Ibs was named No. ... in pharma, and he was honored as a Tech Disruptor by the Philadelphia Business ...
(Date:5/6/2016)... ... 06, 2016 , ... The joy associated with Mother’s Day is mixed with worry and fear ... units (NICUs) across the country. For the first time ever, the March of Dimes ... who spend their Mother’s Day beside a crib surrounded by lifesaving equipment or peering through ...
(Date:5/6/2016)... ... May 06, 2016 , ... Featured cast and producers of ... address at the 2016 Learning Summit , June 12-15, in Paradise Valley, ... Their stories—of complicated family issues, financial difficulties, and other personal obstacles—are the stories ...
Breaking Medicine News(10 mins):
(Date:5/6/2016)... May 6, 2016  Hill-Rom Holdings, Inc. (NYSE: ... declared a fiscal year 2016 third quarter dividend of $0.17 per ... over the amount paid a year ago. The dividend ... of the close of business on June 10, 2016. ... Hill-Rom is a leading global medical technology company with ...
(Date:5/6/2016)... 6, 2016 Appoints Susanta ... its Application to Drug Development Including Development of Radiopharmaceuticals ... the life sciences consulting firm, today announced that it ... Associate Partner in its Cambridge, MA ... PhD, in the firm,s Medical Imaging consulting practice and ...
(Date:5/5/2016)... 2016 Global NASH market ... with rise in obesity will fuel the demand ... few years. The NASH Market is growing at ... account of rising number of obesity among young ... market with no FDA approved therapeutics. Antioxidants, anti-diabetic ...
Breaking Medicine Technology: